Five novel triterpenoid saponins from Hovenia dulcis and their Nrf2 inhibitory activities

Recent progress on triterpenoid derivatives and their anticancer potential

Cancer poses a significant global public health challenge, with commonly used adjuvant or neoadjuvant chemotherapy often leading to adverse side effects and drug resistance. Therefore, advancing cancer treatment necessitates the ongoing development of novel anticancer agents with diverse structures and mechanisms of action. Natural products remain crucial in the process of drug discovery, serving as a primary source for pharmaceutical leads and therapeutic advancements. Triterpenoids are particularly compelling due to their complex structures and wide array of biological activities. Recent research has demonstrated that naturally occurring triterpenes and their derivatives have the potential to serve as promising candidates for new drug development. This review aims to comprehensively explore the anticancer properties of triterpenoids and their synthetic analogs, with a focus on recent advancements. Various aspects, such as synthesis, phytochemistry, and molecular simulation for structure-activity relationship analyses, are summarized. It is anticipated that triterpenoid derivatives will emerge as notable anticancer agents following further investigation into their mechanisms of action and in vivo studies.

Hovendulcisic acid A-D: four novel ceanothane-type triterpenoids from Hovenia dulcis stems with anticancer properties

Sixteen ceanothane-type triterpenoids, including four new compounds-hovendulcisic acids A-D (1-4) -were purified from the stems of Hovenia dulcis Thunb. The structures of 1-4 were confirmed by comprehensive means including ECD and quantum chemical calculations. Putative biosynthetic pathways of 1-16 were proposed, and 3, 5, and 15 exhibited antitumor activity on A549 and MDA-MB-231 cells.

Phenolic Compounds From the Stems and Leaves of Berchemia lineata (L.) DC

Eight new phenolic compounds, named bercheminols A-H (1-8), and eleven known analogues were isolated from the stems and leaves of Berchemia lineata (L.) DC. Their structures including the absolute configurations were elucidated by extensive spectroscopic analysis, chemical method, and quantum chemical calculations. Compound 1 possesses an unprecedented 3,4-dihydro-11H-benzo[b]pyrano[4,3-e] oxepin-11-one skeleton. The other new compounds belong to three structural types of natural products, including naphthopyrones (2-5), flavonoids (6-7), and bibenzyl (8). The α-glucosidase inhibitory activities of the isolated compounds were assayed. As a result, vittarin-B (9), rubrofusarin-6-O-β-D-glucopyranoside (11), quercetin (14), kaempferol (15), and dihydrokaempferol (17) showed moderate inhibitory activities against α-glucosidase with IC50 values of 22.5, 28.0, 36.5, 32.7, and 31.9 μM, respectively.

Isolation, purification, structural characterization, and hypoglycemic activity assessment of polysaccharides from Hovenia dulcis (Guai Zao)

Hovenia dulcis polysaccharides (HDPs) have a variety of important biological activities associated with potential applications in food engineering, pharmacy science, and health care. Herein, we isolated and purified polysaccharides from H. dulcis. Chemical composition analysis revealed that the purified polysaccharides (HDPs-2A) were composed of different molar ratios of mannose, Rha, GalA, GlcA, Glc, Gal, and Ara and had a molecular weight of 372.91 kDa. The structure of HDPs-2A was assessed by FT-IR, periodate oxidation, Smith degradation, methylation analysis, and NMR, allowing us to determine that the backbone of HDPs-2A is composed primarily of →5)-α-L-Araf-(1→, →5)-α-L-Araf-(1→, →3,5)-α-L-Araf-(1→, →6)-β-D-Galp-(1→, →3,6)-β-D-Galp-(1→, T-β-D-Galp, →3)-β-D-Galp-(1→, and T-α-D-Glcp. The results of atomic force microscopy (AFM) showed that HDPs-2A present an irregular polymer particle morphology in water. X-ray diffraction (XRD) results showed that HDPs-2A have a single crystal structure. Finally, we demonstrated that HDPs-2A have a good therapeutic effect on a rat model of type 2 diabetes.